TabletsClinical Overview
L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg) Tablets combines an ammonia-detoxifying metabolic amino acid with digestive pancreatic enzymes. LOLA stimulates urea cycle carbamoyl phosphate synthetase in hepatocytes and glutamine synthesis in skeletal muscle, clearing neurotoxic ammonia. Pancreatin supplies amylase, lipase, and protease to assist nutrient breakdown in patients with compromised digestion. Indicated for hepatic dysfunction, fatty liver, subclinical hepatic encephalopathy, and digestive insufficiency associated with liver cirrhosis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 1 to 2 tablets three times daily with meals with water. Swallow whole; do not chew.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, flatulence, abdominal distension, mild diarrhea. Rare/Severe: Vomiting and hyperuricemia with high enzyme doses.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in severe renal failure (serum creatinine > 3 mg/dL). Porcine origin; caution in patients with pork protein allergies.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Pancreatin 170mg + Activated Dimethicone 80mg Tablets
Pancreatin (170mg) with Bile Salts (Sodium Tauroglycocholate 65mg) and/or Dimethicone (80mg) Tablets is a comprehensive digestive enzyme and emulsifying formulation. Pancreatin provides amylase, lipase, and protease; tauroglycocholate emulsifies dietary fats and activates pancreatic lipase for optimal absorption; dimethicone reduces surface tension of trapped gas bubbles. Indicated for exocrine pancreatic insufficiency, chronic pancreatitis, dyspepsia, fatty food intolerance, and flatulent indigestion.
Pancreatin 170 mg (containing 15000 units of Amylase activity + 4000 units of Lipase activity + 15000 units of Protease activity) + Sodium Tauroglycocholate 65mg Digestive Enzyme Tablets
Pancreatin (170mg) with Bile Salts (Sodium Tauroglycocholate 65mg) and/or Dimethicone (80mg) Tablets is a comprehensive digestive enzyme and emulsifying formulation. Pancreatin provides amylase, lipase, and protease; tauroglycocholate emulsifies dietary fats and activates pancreatic lipase for optimal absorption; dimethicone reduces surface tension of trapped gas bubbles. Indicated for exocrine pancreatic insufficiency, chronic pancreatitis, dyspepsia, fatty food intolerance, and flatulent indigestion.
L- Ornithine L-Aspartate Infusion 5gm per 10ml
L- Ornithine L-Aspartate Infusion 5gm per 10ml is an established pharmaceutical and nutritional agent in the Vitamins, Minerals & Nutrition category on the PMBI National Formulary. Formulated to provide micronutrient replenishment, metabolic support, or nutritional therapy according to verified pharmacopoeial standards.
Metadoxine 500mg + Silymarin 140mg + L- Ornithin L- Aspartate 150mg Tablets
Metadoxine (500mg), Silymarin (140mg), and L-Ornithine L-Aspartate (150mg) Tablets is a hepatoprotective formulation. Silymarin (milk thistle flavonolignan) stabilizes hepatocyte plasma membranes, inhibits lipid peroxidation, and stimulates ribosomal RNA synthesis to accelerate liver regeneration. Metadoxine accelerates ethanol and acetaldehyde clearance, restoring cellular ATP and glutathione. LOLA enhances ammonia detoxification via the hepatic urea cycle. Indicated for alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD/NASH), acute and chronic hepatitis, and early liver cirrhosis.